Novavax (NVAX) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $11.01 -3.67%
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q3 EPS of ($0.12), in-line with the analyst estimate of ($0.12). Revenue for the quarter came in at $7.7 million versus the consensus estimate of $9.4 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Southern Missouri Bancorp (SMBC) Tops Q1 EPS by 7c
- Hexcel falls on revenue miss and weak guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
